Search research articles
Contact Us
Filters
Showing results (1-10 of 161) with videos related to
Page
of 17
Sort By:
Biomed Research International
|
August 15, 2015
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease
Liane Rabinowich, Oren Shibolet
Biologics : Targets & Therapy
|
August 27, 2009
Infliximab in ulcerative colitis
Avi Levin, Oren Shibolet
Seminars in Liver Disease
|
June 11, 2013
Immunosuppression and HBV reactivation
Daniel Shouval, Oren Shibolet
World Journal of Gastroenterology
|
September 9, 2008
Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory
Avi Levin, Oren Shibolet
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
June 8, 2007
TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction
Oren Shibolet, Daniel K Podolsky
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 4, 2004
Hepatic hydrothorax--pathophysiology, diagnosis and treatment--review of the literature
Chamutal Gur, Yaron Ilan, Oren Shibolet
World Journal of Gastroenterology
|
August 16, 2019
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Hadar Meringer, Oren Shibolet, Liat Deutsch
Journal of Hepatology
|
October 11, 2021
Reply to: "Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!"
Liane Rabinowich, Oren Shibolet, Helena Katchman
World Journal of Hepatology
|
April 8, 2015
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
Liat Mlynarsky, Yoram Menachem, Oren Shibolet
Cancers
|
January 11, 2022
Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
Shira Zelber-Sagi, Mazen Noureddin, Oren Shibolet
Page
of 17
Search research articles
Search
Showing results (1-10 of 161) with videos related to
Sort By:
Page
of 17
Biomed Research International
|
August 15, 2015
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease
Liane Rabinowich, Oren Shibolet
Biologics : Targets & Therapy
|
August 27, 2009
Infliximab in ulcerative colitis
Avi Levin, Oren Shibolet
Seminars in Liver Disease
|
June 11, 2013
Immunosuppression and HBV reactivation
Daniel Shouval, Oren Shibolet
World Journal of Gastroenterology
|
September 9, 2008
Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory
Avi Levin, Oren Shibolet
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
June 8, 2007
TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction
Oren Shibolet, Daniel K Podolsky
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 4, 2004
Hepatic hydrothorax--pathophysiology, diagnosis and treatment--review of the literature
Chamutal Gur, Yaron Ilan, Oren Shibolet
World Journal of Gastroenterology
|
August 16, 2019
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Hadar Meringer, Oren Shibolet, Liat Deutsch
Journal of Hepatology
|
October 11, 2021
Reply to: "Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!"
Liane Rabinowich, Oren Shibolet, Helena Katchman
World Journal of Hepatology
|
April 8, 2015
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
Liat Mlynarsky, Yoram Menachem, Oren Shibolet
Cancers
|
January 11, 2022
Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
Shira Zelber-Sagi, Mazen Noureddin, Oren Shibolet
Page
of 17